Noninvasive Prenatal Testing (NIPT): Risks & Benefits

Noninvasive prenatal testing (NIPT) screens for genetic conditions in the fetus using a maternal blood sample. It provides information on fetal chromosomes and risk of certain genetic disorders.

Common NIPT Tests

  • Cell-free DNA (cfDNA) testing: Analyzes placental DNA fragments in maternal blood. Assesses risk of chromosomal abnormalities (Down syndrome, trisomy 18).
  • Maternal serum screening: Measures substances (AFP, hCG) in maternal blood. Assesses chromosomal abnormalities and neural tube defects (spina bifida).
  • Combined screening: Combines cfDNA and serum screening for more accurate risk assessment.

Important Considerations

NIPT is safe and accurate as a screening test, but not diagnostic. If results indicate increased risk, diagnostic tests (amniocentesis, chorionic villus sampling) may be recommended for confirmation.

Pregnancy & Health - Related Articles